Eversight is a global nonprofit eye bank with a mission to restore sight and prevent blindness through the healing power of donation, transplantation and research.

One billion people are coping with preventable vision loss globally. This includes 12 million who suffer from corneal blindness, making this condition the fourth leading cause of blindness worldwide.

Eversight and our many dedicated partners are working to address this global burden and help make vision a reality for more people worldwide.

Our Focus

Donation

Restored sight begins with the generosity of eye donors and their families.

Learn more

Transplantation

Cornea transplants give people the chance to see a bright future.

Learn more

Research

Groundbreaking discoveries transform the future of vision therapies.

Learn more

Global vision

Our impact gives hope to people in need around the world.

Learn more

News & Stories

The Youngstown Foundation
The Youngstown Foundation grant to support clinical operations in northeast Ohio
CLEVELAND, May 1, 2024 – The Youngstown Foundation has awarded Eversight a $5,000... read more
CLEVELAND, May 1, 2024 – The Youngstown Foundation has awarded Eversight a $5,000... read more Full Story
2024 grant recipients
2024 grant recipients aim to advance promising eye and vision research
2024 Eversight Eye & Vision Research grants were awarded to investigators at Tufts... read more
2024 Eversight Eye & Vision Research grants were awarded to investigators at Tufts... read more Full Story
Eversight cornea fellow
Eversight’s supplemental fellowship pioneers research, elevates skills & education
Eversight Academy proudly sponsors a supplemental eye banking and vision research... read more
Eversight Academy proudly sponsors a supplemental eye banking and vision research... read more Full Story
ASCRS conference
Beyond the conference: Go behind the scenes at ASCRS with Eversight
April 26, 2024 – Eversight team members recently attended the 2024 American Society of... read more
April 26, 2024 – Eversight team members recently attended the 2024 American Society of... read more Full Story